definiens: shall mean when a generic pharmaceutical product that is therapeutically equivalent to the Product is sold in the Territory and Unit sa les of the Product in the Territory in any subseque nt [ * * ] ( [ * * ] ) sequential calendar quarters decrease by [ * * ] perce nt ( [ * * ] % ) or more as compared to the prior [ * * ] ( [ * * ] ) sequential calendar quarters of sales . As used in t his definition, means that, for purposes of the United States, an AB rating is assi gned to the product ’s entry in the list of drug pro ducts with effective approvals published in the then - current e dition of FDA ’s publication and any curren t supplement to the publication ( also known as the ) referred to in 21 CFR 314.3 and such product is covered by an Abbreviated New Drug Application ( as defined in the FDC Act ) . For purposes of other coun tries in the Territory, as used in this definition, means that a rating eq uivalent to the FDA ’s AB rating is assigned to the product by that country ’s Regulatory Authority